All Clinical Trials
Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.
Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.
NRG-CC014, Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT) (NCT06745024)
Study # NRG-CC014 Date Opened: 06/09/2025 Closing Date: 10/01/2028 Principal Investigator: Jason T. Shumadine, M.D. Sponsor: NRG Oncology
NRG-LU008, Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
Study # NRG-LU008 Date Opened: 07/12/2023 Closing Date: 10/15/2031 Principal Investigator: David Perry, M.D. Sponsor: NRG Oncology
NRG-BN013, Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) versus Fractionated SRS (FSRS) for Intact Brain Metastases
Study # NRG-BN013 Date Opened: 12/12/2024 Closing Date: 06/30/2028 Principal Investigator: David Perry, M.D. Sponsor: NRG Oncology
NRG-GI011: A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
Study # NRG-GI011 Date Opened: 07/15/2025 Closing Date: 10/21/2030 Principal Investigator: David Perry, M.D. Sponsor: NRG Oncology
